Creative Medical’s BioDefense initiative receives regulatory approval
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) announced regulatory approval for its BioDefense Inc. Burn Pit Initiative, aiming to develop a molecular and cellular database for veterans exposed to toxic burn pits. The initiative will leverage AI and iPSC technology using existing partnerships, without requiring new fundraising, despite the company's recent stock volatility and net loss. The company highlights its strong short-term liquidity with a current ratio of 20.71, as per InvestingPro data.